Menthosomes: A Comprehensive Review

Introduction

In recent years, there has been a surge in the development of advanced drug delivery systems aimed at overcoming the limitations of conventional routes of administration. One of the most significant challenges in drug delivery is the poor bioavailability of active pharmaceutical ingredients (APIs), which is often attributed to barriers such as the skin’s stratum corneum or the gastrointestinal tract’s enzymatic environment¹. To address these challenges, researchers have focused on creating more efficient, targeted, and controlled release systems. Among the promising innovations in this area are menthosomes, a novel class of vesicular drug delivery systems that incorporate menthol into their structure to enhance the delivery of therapeutic agents. Menthosomes are lipid-based vesicles that derive from liposomes or ethosomes, but they stand apart due to the incorporation of menthol, a compound extracted from peppermint oil². Menthol is well-known for its cooling, soothing, and permeation-enhancing properties, which make it an ideal candidate for improving drug absorption through biological membranes, especially the skin. When integrated into vesicular systems, menthol not only facilitates the enhanced penetration of drugs but also improves the overall stability, fluidity, and encapsulation efficiency of the vesicles. These features are particularly useful for drug delivery applications that require increased bioavailability, sustained release, and efficient permeation through the skin or mucosal surfaces³.

Composition

Menthosomes are a type of nano-carrier system designed for enhancing the delivery of therapeutic agents or active compounds, particularly in the field of drug delivery. These nanocarriers typically consist of liposomes, which are lipid-based structures, but with added functionalization to increase their effectiveness. Here’s a breakdown of the composition of menthosomes in detail⁴:

Phospholipids

The core structure of a menthosome is composed of phospholipids, which are the primary building blocks of the lipid bilayer. Phospholipids are amphiphilic molecules, meaning they have both hydrophilic (water-attracting) and hydrophobic (water-repellent) regions. This amphipathic nature allows phospholipids to form bilayers in aqueous environments, which is essential for the formation of liposomes or menthosomes. Commonly used phospholipids include:

Lecithin (phosphatidylcholine)

Phosphatidylethanolamine

Phosphatidyl serine⁵.

Menthol

The defining feature of menthosomes is the inclusion of menthol, a natural compound often derived from peppermint oil. Menthol has been found to enhance the permeability of the lipid bilayer and improve the delivery of active compounds by interacting with the skin or mucosal surfaces. The menthol molecules can be incorporated into the liposomal structure or used to modify the surface properties of the carrier. Menthol can also enhance the transdermal delivery of drugs due to its cooling and soothing properties⁶.

Cholesterol

Cholesterol is often added to the formulation of menthosomes to provide additional stability to the lipid bilayer. It reduces the permeability of the liposomes and increases the rigidity of the membrane, which helps protect the encapsulated drug from degradation. Cholesterol also aids in the maintenance of liposomal fluidity, allowing for better fusion with cell membranes and facilitating the release of the encapsulated agent⁷.

 Surfactants

Surfactants are commonly included in menthosomes to improve the dispersion and solubility of the formulation. Non-ionic surfactants such as Polysorbate 80 (Tween 80) or Span 60 are frequently used to reduce surface tension, improve drug encapsulation efficiency, and ensure better stability of the menthosome system. These surfactants can help in forming a stable and homogeneous dispersion of the liposomal nanoparticles⁸.

Water and Aqueous Phase

The aqueous phase inside the liposomes or menthosomes holds the hydrophilic compounds. The bilayer formed by the phospholipids encapsulates the aqueous core, and in the case of menthosomes, this system might also allow the encapsulation of menthol, which can aid in the enhanced permeability of certain drugs⁹.

Structure of Menthosomes

Menthosomes are liposomal structures that contain menthol as an integral part of their lipid bilayer or as a co-solvent in the aqueous phase. The structure of menthosomes can be outlined as follows:

Lipid Bilayer

The outer membrane of menthosomes consists of a lipid bilayer, which can be made from various lipid materials such as phospholipids (e.g., lecithin, cholesterol). This bilayer is similar to the structure of natural cell membranes, providing stability and flexibility to the vesicle¹⁰.

Menthol Incorporation

Menthol, a volatile compound, can be embedded within the lipid bilayer or solubilized in the aqueous core of the vesicle. The inclusion of menthol in the structure enhances the vesicle’s ability to penetrate skin layers, improve the solubility of lipophilic drugs, and provide a cooling effect, which is beneficial in dermatological applications¹¹.

Encapsulation of Active Ingredients

Active pharmaceutical ingredients (APIs) can be encapsulated within the menthosome structure, which helps protect these sensitive compounds from degradation and enables controlled release¹².

Figure 1: Structure of Menthosomes   Click here to View Figure

Size and Charge

Menthosomes typically range in size from 50 nm to several micrometers. They may also carry a surface charge depending on the lipid composition used in their formulation, which influences their interaction with biological membranes¹³.

Mechanism of Action of Menthosomes

The mechanism of action of menthosomes is largely related to their ability to enhance the delivery and absorption of encapsulated drugs, especially in topical applications. This mechanism can be explained through the following points:

Enhanced Skin Penetration

Menthol, when incorporated into the menthosome structure, facilitates the penetration of the vesicle through the skin barrier. Menthol acts as a skin permeation enhancer by disrupting the lipid layers in the stratum corneum, the outermost layer of the skin. This disruption increases the permeability of the skin and allows for the deeper penetration of the vesicle, carrying the encapsulated drugs¹⁴.

Cooling and Sensory Effects

Menthol is known for its cooling effect, which provides a sensory experience when applied topically. This cooling sensation occurs due to menthol’s ability to activate cold-sensitive receptors (TRPM8) in the skin. The presence of menthol in menthosomes can enhance the therapeutic effect by providing both a physical cooling effect and a psychological soothing effect for the patient¹⁵.

Controlled Release

Menthosomes offer controlled release of their encapsulated drug payloads. The liposomal structure allows for the slow and sustained release of the active ingredient over time, reducing the frequency of administration and enhancing therapeutic efficacy. This controlled release is influenced by factors such as the lipid composition, size, and surface charge of the menthosome¹⁶.

Stabilization of Active Ingredients

The encapsulation of drugs in menthosomes protects sensitive active ingredients from degradation due to environmental factors such as light, heat, and oxidation. This stabilization allows for a longer shelf-life and ensures the stability of the encapsulated compounds when applied to the skin or other biological surfaces¹⁷.

Targeted Delivery

In some cases, menthosomes may be designed for targeted delivery to specific tissues or skin layers. The lipid bilayer can be modified with surface-active agents or functionalized to enhance targeting ability, ensuring that the menthosome delivers its payload to the desired site of action¹⁸.

 Formulation approaches of Menthosomes

Menthosomes are specialized vesicular carriers that are used to enhance the transdermal delivery of active ingredients. They are essentially liposomes modified with menthol, which acts as a penetration enhancer. The formulation of menthosomes involves the careful selection of ingredients and techniques to achieve effective drug delivery through the skin. Here are some key formulation approaches used to develop menthosomes¹⁹.

Liposome-Based Formulation

Menthosomes are typically made by modifying conventional liposomes with menthol. The process of formulating menthosomes usually involves the preparation of a phospholipid bilayer using lipids such as phosphatidylcholine, which encapsulates the active substance. Menthol is incorporated into the lipid phase or used as a co-solvent in the formulation to enhance skin permeability¹⁹.

Method: The liposome preparation can be done through methods like thin-film hydration, solvent evaporation, or reverse-phase evaporation. During this, menthol is introduced either by direct inclusion in the lipid matrix or as part of the hydration medium²⁰.

Hydration Method    

This is the most commonly used approach for the preparation of menthosomes. The lipid components (like phosphatidylcholine, cholesterol, and menthol) are dissolved in an organic solvent such as chloroform, followed by the evaporation of the solvent under reduced pressure. After solvent removal, the lipid film is hydrated with an aqueous phase containing the active ingredient. The hydration process results in the formation of vesicles²¹ .

Menthol Role: Menthol can be incorporated into the lipid phase during the hydration step. It is believed to increase the fluidity of the lipid bilayer, improving the release rate and stability of the drug encapsulated in the vesicles²².

Reverse Phase Evaporation Method

In this method, a water-in-oil emulsion is first prepared using an aqueous solution containing the active ingredient and an organic solvent containing the lipids. This is followed by solvent evaporation, leading to the formation of a bilayer structure. The reverse-phase evaporation method is particularly useful for encapsulating hydrophilic and hydrophobic drugs within menthosomes, providing a versatile approach for a range of drug delivery applications²³.

Solvent Injection Method

In this method, lipids are dissolved in an organic solvent and then injected into an aqueous phase under controlled conditions. The solvent rapidly evaporates, leading to the formation of menthosomes. The use of menthol in the solvent phase facilitates its incorporation into the lipid structure, aiding in drug penetration.

Challenges in formulating Menthosomes

Formulating menthosomes involves several challenges due to their unique structure and properties. Menthosomes are liposomal systems that encapsulate menthol, aiming for controlled release or enhanced skin penetration. Some of the key difficulties in their formulation include²⁴:

Incorporation of menthol

Solubility Challenges

Since menthol has low solubility in water, integrating it into water-based formulations can be tricky. Proper techniques must be used to ensure menthol is adequately dissolved and incorporated into the liposome structure.

Retention of Menthol

Ensuring that menthol stays encapsulated within the liposomes without leaking prematurely is a significant hurdle during formulation²⁵.

Liposome Formulation

Selection of Lipid Materials

The choice of lipids, such as phospholipids or cholesterol, plays a critical role in achieving efficient encapsulation and maintaining liposomal stability. The lipid composition needs to be optimized for the best balance between stability and menthol retention.

Size and Uniformity

Achieving a uniform size distribution and preventing aggregation of liposomes is essential for formulation consistency. Techniques like sonication or high-pressure homogenization need to be carefully controlled to ensure proper vesicle formation²⁶.

Release dynamics

Controlled Release

A key objective of menthosomes is to provide a controlled, sustained release of menthol. Balancing the release of menthol over time while preserving its effectiveness requires careful formulation adjustments.

Skin or Mucosal Tissue Interaction

Skin Penetration

Effective delivery of menthol to deeper layers of the skin or mucosal tissues is a challenge, as the formulation must be designed for optimal penetration without causing irritation.

Sensory Effects

Menthol is known for its cooling sensation, and controlling this effect is crucial. Rapid or excessive menthol release could lead to discomfort or an unpleasant sensory experience²⁷.

Regulatory and safety concern

Safety Concerns

The safety of menthosomes must be thoroughly assessed, particularly with regard to skin irritation and potential toxicity. Both the menthol and liposomal ingredients need to meet safety standards.

Regulatory Compliance

Depending on the region, there are strict guidelines regarding the use of menthol in products, which must be adhered to during formulation and testing to obtain regulatory approval²⁸.

Methods to overcome challenges

Stability Issues

Use of Stabilizing Agents

To prevent physical instability like aggregation or fusion, stabilizing agents such as polyethyleneglycol (PEG) or other surfactants can be incorporated into the formulation. These agents help to stabilize the liposomes and reduce their tendency to aggregate.

Encapsulation Optimization

The lipid composition, including the use of cholesterol or other rigid lipids, can be adjusted to increase the stability of the liposomal bilayer. This helps prevent the premature leakage of menthol and improves the overall shelf life of the menthosomes.

Antioxidants

Including antioxidants (e.g., vitamin E or ascorbic acid) can help prevent the chemical degradation of menthol and other components within the liposomes, especially when exposed to oxygen and light²⁹.

Incorporation of menthol

Solubilization Techniques

To overcome the poor solubility of menthol in water, techniques like co-solvent systems, use of surfactants, or the formation of menthol complexes with other substances (such as cyclodextrins) can be employed. These methods enhance menthol’s solubility and improve its incorporation into the liposomes.

Encapsulation Efficiency Enhancement

To improve the retention of menthol, factors like optimizing the lipid-to-water ratio, using higher concentrations of phospholipids, or employing methods like reverse-phase evaporation or ethanol injection can improve menthol encapsulation and minimize leakage³⁰.

Liposome formulation

Optimization of Lipid Composition

Careful selection of lipids is critical. The inclusion of lipids like phosphatidylcholine, phosphatidylethanolamine, or sphingolipids, along with cholesterol, can create more stable liposomal membranes that are less prone to leakage and rupture.

Size Reduction Techniques

The size and uniformity of liposomes can be controlled by applying techniques like high-pressure homogenization, extrusion through membranes with defined pore sizes, or sonication. These methods allow precise control over the size distribution and prevent aggregation.

Cryoprotection and Lyophilization

To improve long-term storage stability, menthosomes can be lyophilized (freeze-dried) after encapsulating menthol. Cryoprotectants like sucrose or trehalose can be added to preserve the liposome structure during the drying process³¹.

Release kinetics

Controlled Release Systems:

To ensure controlled release of menthol, formulations can incorporate slow-releasing lipids or crosslinking agents to modulate the release rate. Polymer-lipid hybrid systems or the inclusion of biodegradable polymers can help achieve a more gradual release profile.

Multilamellar Vesicles (MLVs)

Using MLVs, which have multiple lipid layers, can extend the release of menthol over a longer duration, reducing the burst release and providing sustained action³².

Skin or mucosal tissue interactions

Penetration Enhancers

To ensure menthol reaches deeper layers of the skin, chemical penetration enhancers like ethanol, oleic acid, or other lipid-based substances can be added to the formulation. These enhance the permeability of the stratum corneum, allowing better menthol absorption.

pH Adjustments

Formulating menthosomes with an optimal pH (around 5.5-6.0) can ensure that the menthol is effectively released while minimizing irritation or discomfort upon application to the skin or mucosa³³.

Regulatory and safety concerns

In-depth Safety Testing

Comprehensive safety evaluations, including skin irritation tests, toxicity assessments, and allergenicity screening, should be conducted to ensure the product is safe for its intended use.

Regulatory Compliance

Ensuring that the ingredients, formulation processes, and final product meet local and international regulatory standards (e.g., FDA, EMA) is crucial. Detailed documentation, including safety and efficacy data, must be provided to regulatory agencies for approval.

Natural and Non-toxic Ingredients

Using biocompatible and non-toxic ingredients in the formulation, such as naturally derived lipids, can help meet safety standards and appeal to consumers looking for eco-friendly or skin-safe products³⁴.

Characterization of Menthosomes

Menthosomes are specialized lipid-based vesicular structures that are designed to encapsulate and deliver active ingredients efficiently, particularly for pharmaceutical or cosmetic applications. They are primarily composed of phospholipids and menthol, which enhance their permeability.

Particle Size and Distribution:

The particle size is a critical parameter as it determines the release rate and bioavailability of the encapsulated substance. Typically, dynamic light scattering (DLS) is used to measure the particle size and the polydispersity index (PDI), which reflects the uniformity of the vesicles³⁵.

Zeta Potential:

Zeta potential indicates the surface charge of the menthosomes, which influences their stability. A higher absolute value of zeta potential generally correlates with improved stability due to electrostatic repulsion between the particles. It is measured using electrophoretic light scattering.

Morphology and Structure:

The shape and surface characteristics of menthosomes can be analyzed using techniques like Transmission Electron Microscopy (TEM) or Scanning Electron Microscopy (SEM). These techniques provide high-resolution images of the vesicular structure and surface smoothness, crucial for determining their suitability in drug or cosmetic delivery²¹.

Characteristics of menthosomes

|Property	Menthosomes
Vesicle Size	~100–200 nm (nanometric range)
Surface Charge	Slightly negative (Zeta potential)
Entrapment Efficiency	High for lipophilic and moderately hydrophilic drugs
Skin Permeation	Superior due to menthol + deformability
Drug Release	Sustained over several hours

Encapsulation Efficiency

Encapsulation efficiency is calculated to determine how effectively the active ingredient is incorporated within the vesicle. It is determined by separating the free drug from the encapsulated one using methods like ultracentrifugation or dialysis, and then quantifying the amount of active ingredient using spectrophotometry or HPLC (HighPerformance Liquid Chromatography).

Thermal Analysis

Differential Scanning Calorimetry (DSC) or Thermogravimetric Analysis (TGA) can be used to study the thermal properties of menthosomes. These analyses help in understanding the phase transition temperature, stability under different temperatures, and the interaction of components like menthol with lipids³⁶.

In Vitro Release Studies

To assess the release profile of the encapsulated substance, in vitro release studies are conducted. This typically involves using diffusion cell apparatus to simulate skin or mucosal environments, tracking the release of the active ingredient over time.

Stability Studies

Stability of menthosomes is vital for their practical use. Physical stability (e.g., aggregation or sedimentation) and chemical stability (e.g., degradation of the encapsulated compound) are assessed under various conditions such as temperature, pH, and light exposure.

Skin Permeability and Penetration

Since menthosomes are often designed for topical applications, the ability of the vesicles to penetrate the skin is crucial. In vitro skin permeation studies, using models like Franz diffusion cells, can evaluate how well the menthosomes deliver their active ingredients across different skin layers³⁷.

Applications of menthosomes

Menthosomes are a specialized type of nano-sized vesicles made of menthol (or menthol derivatives) and phospholipids. They have garnered interest in recent years for their unique properties, particularly in drug delivery systems. Here’s a detailed overview of their applications across various fields

Drug Delivery Systems

Transdermal drug delivery

Menthol, a key component in menthosomes, has a wellknown ability to improve skin permeability by temporarily opening pores and increasing drug absorption. This property is leveraged in menthosomes to deliver active pharmaceutical ingredients (APIs) through the skin more effectively.

Targeted drug delivery

The incorporation of menthol helps in targeting drugs to specific tissues or organs, improving the therapeutic efficacy and reducing side effects. The menthosomal structure can encapsulate both hydrophilic and lipophilic drugs, offering versatility in drug delivery³⁸.

Cosmetic formulations

Anti-aging treatments

Menthosomes enhance the skin penetration of anti-aging agents, such as retinoids and peptides, improving their effectiveness.

Skin hydration and nourishment

Incorporating menthosomes in moisturizers allows the gradual release of hydrating ingredients, which can reach deeper layers of the skin.

Sun protection

In sunscreen formulations, menthosomes can encapsulate sunscreen agents, improving their stability and ensuring a prolonged release on the skin’s surface.

Wound healing and Dermatology

Promote skin regeneration

By facilitating the delivery of growth factors, antibiotics, and other healing agents directly to the wound site, menthosomes accelerate the healing process.

Anti-inflammatory effects

The menthol in menthosomes has mild analgesic and antiinflammatory properties, which can help reduce pain and inflammation at the wound site, contributing to faster recovery³⁹.

Cancer Therapy

Targeted drug delivery to tumor cells

Menthosomes can be designed to target cancer cells by incorporating ligands that bind to cancer cell-specific receptors. This helps to concentrate the drug in the tumor site while minimizing systemic side effects.

Increased bioavailability of drugs

Since menthosomes can improve the solubility of poorly soluble drugs, they offer a way to enhance the bioavailability of cancer drugs, making them more effective at lower doses⁴⁰.

Improvement of oral Bio availability

Menthosomes can also be used in oral drug delivery systems to enhance the absorption of drugs that are poorly bioavailable. The menthol helps in increasing the permeability of the gastrointestinal tract, facilitating the absorption of drugs. This is particularly useful for drugs that have limited solubility or absorption issues when administered orally⁴¹.

Antibacterial and Antifungal activity

Antibacterial delivery

By encapsulating antibiotics or antimicrobial peptides within menthosomes, their effectiveness can be enhanced, and the release can be controlled, ensuring sustained antimicrobial action.

Fungal infections

Menthol’s natural antifungal properties, when combined with the vesicular structure, can help deliver antifungal agents more efficiently to affected areas, leading to improved treatment outcomes⁴².

Vaccine and Immune therapy

Improved vaccine efficacy

The vesicular nature of menthosomes can be used to encapsulate and protect antigens, improving the stability and immune response to vaccines.

Adjuvant properties

Menthol has immune-modulating effects, and when incorporated into menthosomes, it could enhance the body’s immune response to vaccines, making them more effective.

Neuropharmacological Applications

Menthosomes may have applications in neuropharmacology by enhancing the delivery of drugs to the brain. The menthol in the system can help increase the permeability of the blood-brain barrier, making it easier to deliver therapeutic agents for neurological conditions such as Alzheimer’s disease, Parkinson’s disease, and other central nervous system disorders⁴³.

Advantages of Menthosomes

Menthosomes are a specialized type of liposomal carrier system that incorporate menthol, a naturally occurring compound, into lipid-based vesicles. These vesicles are designed to encapsulate active pharmaceutical ingredients (APIs) or cosmetic agents and improve their delivery to target sites, often through the skin. The unique properties of menthosomes due to the combination of menthol and phospholipids offer a variety of advantages, especially in drug delivery and skincare applications. Below is a detailed explanation of these advantages⁴⁴:

Enhanced skin penetration

Menthol plays a key role in improving the permeability of the skin, which is a major barrier to the effective delivery of many active ingredients. Skin is a relatively impermeable barrier, particularly to large or hydrophilic molecules, which can limit the efficacy of topical treatments. Menthol, being a known penetration enhancer, can disrupt the lipid bilayer of the stratum corneum (the outermost layer of skin), allowing the active ingredients in menthosomes to penetrate deeper into the skin.

How it works

Menthol interacts with the skin’s lipid matrix, reducing the barrier effect of the skin and allowing the menthosomes to pass through more efficiently. The lipid membrane of the menthosome also mimics the skin’s own lipid layers, which enhances its ability to fuse with the skin layers and release the encapsulated ingredients⁴⁵.

Targeted delivery

Menthosomes, as vesicular carriers, can encapsulate a wide range of active agents, including drugs, vitamins, and cosmetic ingredients, and deliver them to specific target sites. The liposomal structure allows the ingredients to be protected from degradation before reaching their target area.

How it works

The vesicles can be designed to release their contents at specific locations. For instance, when menthosomes are applied topically, they can target localized skin issues like acne, eczema, or pain sites. This targeted delivery enhances the therapeutic effects while reducing unwanted systemic absorption, which leads to side effects⁴⁶.

Controlled Release

Menthosomes offer controlled release of encapsulated substances over an extended period. This feature is crucial for improving the overall efficacy of the treatment and minimizing the need for frequent reapplication.

How it works

The phospholipid membrane of the menthosome is designed to release the encapsulated ingredients in a controlled manner as it interacts with the skin or other biological membranes. This controlled release ensures a steady and prolonged therapeutic effect, which is particularly useful for chronic conditions or when the active ingredient needs to be delivered over several hours or days⁴⁷.

Improved stability

The encapsulation of active ingredients within the liposomal structure of menthosomes offers enhanced stability, particularly for sensitive compounds that might degrade in the presence of light, heat, or oxygen⁴⁸.

How it works

The lipid bilayer of the menthosome protects the enclosed substances from environmental factors, thus prolonging their shelf life⁽⁴⁹⁾. In the case of pharmaceutical compounds, this means better preservation of the drug’s potency, while for cosmetic ingredients, it may help maintain the effectiveness of ingredients like vitamins or antioxidants that can easily break down when exposed to the environment⁵⁰.

Reduced Irritation

Menthol itself has a soothing and cooling effect on the skin, which makes menthosomes an ideal formulation for treating skin conditions that cause irritation or inflammation. For example, menthol is often used in creams or gels designed to relieve itching, redness, or irritation caused by conditions such as insect bites, sunburn, or mild burns.

How it works

When menthol is included in the menthosome formulation, it provides a dual effect: it helps cool and soothe the skin while also enhancing the skin’s absorption of active ingredients. This can reduce the risk of skin irritation associated with certain topical treatments, making menthosomes a good option for sensitive skin⁵¹.

Non invasive drug delivery 

Menthosomes offer a non-invasive alternative to traditional drug delivery systems, such as injections or oral medications. Topical administration via menthosomes is an attractive option for many patients, particularly those with needle phobia, difficulties swallowing pills, or those in need of long-term, consistent medication.

How it works

The liposomal structure of menthosomes enables them to deliver therapeutic compounds directly through the skin, avoiding the need for injections or oral ingestion. This non-invasive method can also be less stressful for patients and reduce the risk of complications associated with other drug delivery routes.

Improved Bioavailability

The bioavailability of a drug or active ingredient refers to the proportion of the compound that reaches its target site and becomes biologically active. Menthosomes can enhance bioavailability by improving the solubility and absorption of drugs through the skin or mucous membranes.

How it works

The lipid bilayer of menthosomes helps to solvate hydrophobic drugs, improving their stability and absorption through biological membranes. Furthermore, the addition of menthol can act as a penetration enhancer, making it easier for the active ingredients to pass through skin layers and reach deeper tissues or systemic circulation if needed⁵².

Dual effects (cooling effect and therapeutic effect)

Menthosomes provide the unique advantage of offering both therapeutic effects from the active ingredients and a cooling sensation from the menthol. This makes menthosomes an excellent choice for formulations aimed at soothing discomfort, such as those used in pain relief, muscle relaxation, or headache treatments.

How it works

Menthol causes a cooling effect through the activation of cold-sensitive receptors in the skin. When included in menthosomes, this cooling effect can enhance the comfort of the user while also providing relief from conditions like muscle soreness, headaches, or minor skin irritation. This dual-action approach is particularly beneficial for products like topical pain relievers, anti-inflammatory creams, or anti-itch lotion⁵³.

Versatile Applications

Menthosomes are highly versatile and can be used in a wide range of applications, including pharmaceuticals, cosmetics, and food products.

Pharmaceuticals: Menthosomes can be used for transdermal drug delivery, particularly for pain relief medications (e.g., analgesics), anti-inflammatory drugs, and even hormones for hormone replacement therapy⁵⁴.

Cosmetics: They are commonly used in anti-aging products, moisturizers, and sunscreens, as they help in delivering active ingredients like vitamins (A, C, E), antioxidants, or peptides more effectively to the skin⁵⁵.

Novel applications

Drug/Agent	Therapeutic Area	Outcome
Meloxicam	Anti-inflammatory	Increased skin penetration
Ibuprofen	Pain/arthritis	Reduced edema in animal studies
Ketoconazole	Antifungal	Faster onset, deeper delivery
Vitamin C + E	Cosmeceutical	Antioxidant + brightening effec
Luteolin	Antidepressant	Co-delivery in microneedles

 Conclusion

Menthosomes represent a promising advancement in the field of drug delivery systems. Their unique structure, which combines menthol with liposomal technology, enhances the permeation of drugs through biological membranes, thereby improving the bioavailability of various therapeutic agents. This innovative approach can potentially revolutionize the treatment of various diseases, including those requiring enhanced transdermal delivery. The versatility and effectiveness of menthosomes in improving the stability, release profiles, and targeted delivery of drugs make them an exciting area of research in pharmaceutical sciences. Future studies and clinical trials will be essential to fully understand their potential, optimize formulations, and establish their safety and efficacy across diverse medical applications.

Acknowledgement

The authors are thankful to Raghavendra institute of pharmaceutical education and research –Autonomous, Ananthapur for giving support in data collection in computer lab and also support financially for publication.

Funding Sources

The author(s) received no financial support for the research, authorship, and/or publication of this article.

Conflict of Interest

The author(s) do not have any conflict of interest.

Data Availability Statement

This statement does not apply to this article.

Ethics Statement

This research did not involve human participants, animal subjects, or any material that requires ethical approval.

References

1. Phatale V, Vaiphei KK, Jha S, Patil D, Agrawal M, Alexander A. Overcoming skin barriers through advanced transdermal drug delivery approaches. Journal of controlled release. 2022;351:361-80.
   CrossRef
2. Sivakranth M, AnjumaAra P, Krishnaveni C, Venkatesh E. Ethosomes: a novel vesicular drug delivery system. International Journal of Advances in Pharmaceutical Research. 2012;2(1):16-27.
3. Jose Morilla M, Lilia Romero E. Carrier deformability in drug delivery. Current Pharmaceutical Design. 2016;22(9):1118-34.
   CrossRef
4. Parhi R, Mohanta BC, Jena GK, Sahoo SK. Recent advancements in lipid-based nanocarriers for transdermal drug delivery. Green Sustainable Process for Chemical and Environmental Engineering and Science: Elsevier; 2023. p. 347-401.
   CrossRef
5. Zou L, Cheng M, Hu K, Feng J, Tu L. Vesicular drug delivery systems for oral absorption enhancement. Chinese Chemical Letters. 2024;35(7):109129.
   CrossRef
6. Nayak D, Tippavajhala VK. A comprehensive review on preparation, evaluation and applications of deformable liposomes. Iranian Journal of Pharmaceutical Research: IJPR. 2021;20(1):186.
7. Castañeda-Reyes ED, Perea-Flores MdJ, Davila-Ortiz G, Lee Y, Gonzalez de Mejia E. Development, characterization and use of liposomes as amphipathic transporters of bioactive compounds for melanoma treatment and reduction of skin inflammation: A review. International journal of nanomedicine. 2020:7627-50.
   CrossRef
8. Srivastava V, Singh V, Khatri DK, Mehra NK. Recent trends and updates on ultradeformable and elastic vesicles in ocular drug delivery. Drug Discovery Today. 2023;28(8):103647.
   CrossRef
9. Akram MW, Jamshaid H, Rehman FU, Zaeem M, Khan Jz, Zeb A. Transfersomes: A revolutionary nanosystem for efficient transdermal drug delivery. AAPS PharmSciTech. 2022;23:1-18.
   CrossRef
10. Nayak D, Shetty MM, Halagali P, Rathnanand M, Gopinathan A, John J, et al. Formulation, optimization and evaluation of ibuprofen loaded menthosomes for transdermal delivery. International Journal of Pharmaceutics. 2024;665:124671.
    CrossRef
11. Abdelbari MA, El-Mancy SS, Elshafeey AH, Abdelbary AA. Implementing spanlastics for improving the ocular delivery of clotrimazole: in vitro characterization, ex vivo permeability, microbiological assessment and in vivo safety study. International Journal of Nanomedicine. 2021:6249-61.
    CrossRef
12. Aundhia C, Shah N, Talele C, Zanwar A, Kumari M, Patil S. Enhancing Gene Therapy through Ultradeformable Vesicles for Efficient siRNA Delivery. Pharmaceutical Nanotechnology. 2025;13(1):55-69.
    CrossRef
13. Duangjit S, Obata Y, Sano H, Kikuchi S, Onuki Y, Opanasopit P, et al. Menthosomes, novel ultradeformable vesicles for transdermal drug delivery: optimization and characterization. Biological and Pharmaceutical Bulletin. 2012;35(10):1720-8.
    CrossRef
14. Chen J, Gao Y. Strategies for meloxicam delivery to and across the skin: a review. Drug Delivery. 2016;23(8):3146-56.
    CrossRef
15. Wang H, Meng F. The permeability enhancing mechanism of menthol on skin lipids: a molecular dynamics simulation study. Journal of molecular modeling. 2017;23:1-10.
    CrossRef
16. Sevinç-Özakar R, Seyret E, Özakar E, Adıgüzel MC. Nanoemulsion-based hydrogels and organogels containing propolis and dexpanthenol: Preparation, characterization, and comparative evaluation of stability, antimicrobial, and cytotoxic properties. Gels. 2022;8(9):578.
    CrossRef
17. Oyarzún P, Gallardo-Toledo E, Morales J, Arriagada F. Transfersomes as alternative topical nanodosage forms for the treatment of skin disorders. Nanomedicine. 2021;16(27):2465-89.
    CrossRef
18. Kaur P, Verma S, Tomar B, Vyas M, Kakoty V, Saha P, et al. Exploring Applications of Flexible Vesicular Systems as Transdermal Drug Delivery. Current Drug Delivery. 2024;21(8):1062-72.
    CrossRef
19. Munir M, Zaman M, Waqar MA, Hameed H, Riaz T. A comprehensive review on transethosomes as a novel vesicular approach for drug delivery through transdermal route. Journal of Liposome Research. 2024;34(1):203-18.
    CrossRef
20. Matos C, Lobão P. Non-steroidal anti-inflammatory drugs loaded liposomes for topical treatment of inflammatory and degenerative conditions. Current medicinal chemistry. 2020;27(23):3809-29.
    CrossRef
21. Jafari A, Daneshamouz S, Ghasemiyeh P, Mohammadi-Samani S. Ethosomes as dermal/transdermal drug delivery systems: applications, preparation and characterization. Journal of liposome research. 2023;33(1):34-52.
    CrossRef
22. Nasr G, Greige-Gerges H, Elaissari A, Khreich N. Liposome permeability to essential oil components: a focus on cholesterol content. The Journal of Membrane Biology. 2021;254(4):381-95.
    CrossRef
23. Enaru B, Fărcaş A, Stănilă A, Socaci S, Diaconeasa Z. Novel methods for liposome formulation: advancements and innovations. 2023.
    CrossRef
24. Davidov-Pardo G, McClements DJ. Resveratrol encapsulation: Designing delivery systems to overcome solubility, stability and bioavailability issues. Trends in food science & technology. 2014;38(2):88-103.
    CrossRef
25. Garg V, Singh H, Bimbrawh S, Kumar Singh S, Gulati M, Vaidya Y, et al. Ethosomes and transfersomes: Principles, perspectives and practices. Current drug delivery. 2017;14(5):613-33.
    CrossRef
26. Mahajan M, Kaur M, Thakur S, Singh A, Shahtaghi NR, Shivgotra R, et al. Solid lipid nanoparticles as carrier to increase local bioavailability of acitretin after topical administration in psoriasis treatment. Journal of Pharmaceutical Innovation. 2023;18(1):220-
    CrossRef
27. Mojeiko G, Passos JS, Apolinario AC, Lopes LB. Topical transdermal chemoprevention of breast cancer: where will nanomedical approaches deliver us? Nanomedicine. 2021;16(19):1713-31.
    CrossRef
28. Szymczak J, Cielecka-Piontek J. Fisetin—In search of better bioavailability—From macro to nano modifications: A review. International Journal of Molecular Sciences. 2023;24(18):14158.
    CrossRef
29. Halevas EG, Avgoulas DI, Katsipis G, Pantazaki AA. Flavonoid-liposomes formulations: Physico-chemical characteristics, biological activities and therapeutic applications. European Journal of Medicinal Chemistry Reports. 2022;5:100059.
    CrossRef
30. Zhang ZJ. Dermal and Transdermal Delivery of Oxicams using Deformable Liposomes: Rutgers The State University of New Jersey, School of Graduate Studies; 2021.
31. Yu JY, Chuesiang P, Shin GH, Park HJ. Post-processing techniques for the improvement of liposome stability. Pharmaceutics. 2021;13(7):1023.
    CrossRef
32. Cimino C, Maurel OM, Musumeci T, Bonaccorso A, Drago F, Souto EMB, et al. Essential oils: Pharmaceutical applications and encapsulation strategies into lipid-based delivery systems. Pharmaceutics. 2021;13(3):327.
    CrossRef
33. Gaynanova G, Vasileva L, Kashapov R, Kuznetsova D, Kushnazarova R, Tyryshkina A,. Self-assembling drug formulations with tunable permeability and biodegradability. Molecules. 2021;26(22):6786.
    CrossRef
34. Mignani S, Rodrigues J, Tomas H, Roy R, Shi X, Majoral J-P. Bench-to-bedside translation of dendrimers: Reality or utopia? A concise analysis. Advanced drug delivery reviews. 2018;136:73-81.
    CrossRef
35. Mendes T, Gaspar MM, Simöes S, Ascenso A. Lipid Vesicles for Skin Delivery: Evolution from First Generation. Carrier-Mediated Dermal Delivery: Jenny Stanford Publishing; 2017. p. 281-321.
    CrossRef
36. Krishnaswami V, Sugumaran A, Perumal V, Manavalan M, Kondeti DP, Basha SK, et al. Nanoformulations-insights towards characterization techniques. Current Drug Targets. 2022;23(14):1330-44.
    CrossRef
37. Al-Mahallawi AM, Abdelbary AA, Aburahma MH. Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam. International journal of pharmaceutics. 2015;485(1-2):329-40.
    CrossRef
38. Ranjbar S, Emamjomeh A, Sharifi F, Zarepour A, Aghaabbasi K, Dehshahri A, et al. Lipid-based delivery systems for flavonoids and flavonolignans: Liposomes, nanoemulsions, and solid lipid nanoparticles. Pharmaceutics. 2023;15(7):1944.
    CrossRef
39. Jiménez-Rodríguez A, Martínez-Alvarado L, Serrano-Sandoval SN, Romero-Robles LE, Antunes-Ricardo M. Liposomal drug-delivery system in cosmetics. Nanocosmetics: CRC Press. p. 109-38.
    CrossRef
40. Wadher K, Trivedi S, Rarokar N, Umekar M. Development and assessment of rutin loaded transfersomes to improve ex vivo membrane permeability and in vitro efficacy. Hybrid Advances. 2024;5:100144.
    CrossRef
41. Machado TC, Gelain AB, Rosa J, Cardoso SG, Caon T. Cocrystallization as a novel approach to enhance the transdermal administration of meloxicam. European Journal of Pharmaceutical Sciences. 2018;123:184-90.
    CrossRef
42. Zaky A. Comparative study of terbinafine hydrochloride transfersome, menthosome and ethosome nanovesicle formulations via skin permeation and antifungal efficacy. Al-Azhar Journal of Pharmaceutical Sciences. 2016;54(1):18-36.
    CrossRef
43. Harwansh RK, Mishra S, Mazumder R, Deshmukh R, Rahman A. Recent Updates on Transdermal Drug Delivery Approaches for the Management of Gout and its Clinical Perspective. Current Pharmaceutical Biotechnology. 2024;25(2):159-78.
    CrossRef
44. Steyn JD, Haasbroek-Pheiffer A, Pheiffer W, Weyers M, van Niekerk SE, Hamman JH, et al. Evaluation of Drug Permeation Enhancement by Using In Vitro and Ex Vivo Models. Pharmaceuticals. 2025;18(2):195.
    CrossRef
45. Manjushree H, Nayak D, Halagali P, Rathnanand M, Tawale R, Ananthmurthy K, et al. Menthol-based Novel Ultra-Deformable Vesicle: Formulation, Optimization and Evaluation of an Antifungal Drug. AAPS PharmSciTech. 2025;26(1):1-18.
    CrossRef
46. Saleem S, Iqubal MK, Garg S, Ali J, Baboota S. Trends in nanotechnology-based delivery systems for dermal targeting of drugs: An enticing approach to offset psoriasis. Expert Opinion on Drug Delivery. 2020;17(6):817-38.
    CrossRef
47. Salatin S, Lotfipour F, Jelvehgari M. A brief overview on nano-sized materials used in the topical treatment of skin and soft tissue bacterial infections. Expert Opinion on Drug Delivery. 2019;16(12):1313-31.
    CrossRef
48. Mukherjee B, Sengupta S, Banerjee S, Dhara M, Al Hoque A, Kumari L, et al. Transdermal Nanomedicines for Reduction of Dose and Site-Specific Drug Delivery. Nano Medicine and Nano Safety: Recent Trends and Clinical Evidences. 2020:175-211.
    CrossRef
49. Karra VS. Modeling Rosette Nanotubes and Hypo-Elastic Lipid Nanocarriers Using Molecular Dynamics for Drug Delivery Applications: Northeastern University; 2022.
50. Kusumawati I, Indrayanto G. Natural antioxidants in cosmetics. Studies in natural products chemistry. 2013;40:485-505.
    CrossRef
51. Jackson LM, Schwinn DA, National Academies of Sciences E, Medicine. A Review of the Safety and Effectiveness of Select Ingredients in Compounded Topical Pain Creams. Compounded Topical Pain Creams: Review of Select Ingredients for Safety, Effectiveness, and Use. 2020.
    CrossRef
52. Abdulbaqi IM, Darwis Y, Assi RA, Khan NAK. Transethosomal gels as carriers for the transdermal delivery of colchicine: statistical optimization, characterization, and ex vivo evaluation. Drug design, development and therapy. 2018:795-813.
    CrossRef
53. Ah Y-C, Choi J-K, Choi Y-K, Ki H-M, Bae J-H. A novel transdermal patch incorporating meloxicam: in vitro and in vivo characterization. International Journal of Pharmaceutics. 2010;385(1-2):12-9.
    CrossRef
54. Asghar Z, Jamshaid T, Sajid-ur-Rehman M, Jamshaid U, Gad HA. Novel transethosomal gel containing miconazole nitrate; development, characterization, and enhanced antifungal activity. Pharmaceutics. 2023;15(11):2537.
    CrossRef
55. Montenegro L. Nanocarriers for skin delivery of cosmetic antioxidants. Journal of pharmacy & pharmacognosy research. 2014;2(4):73-92.
    CrossRef